SCHEMBL7209786

SCHEMBL7209786

CCCNC(=O)[C@H](Cc1ccccc1)NC(=O)C1OC1C(=O)Nc1ccc(CC)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.52
TACR2 P21452 2/20 0.49
KMT2A Q03164 2/20 0.47
CAPN1 P07384 4/20 0.46
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.44
F13A1 P00488 1/20 0.43
TGM2 P21980 1/20 0.43
PRSS1 P07477 2/20 0.42
PRSS2 P07478 2/20 0.42
PRSS3 P35030 2/20 0.42
KLKB1 P03952 2/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA4 P43681 1/20 0.42
F7 P08709 1/20 0.42
MMP2 P08253 1/20 0.42
PLG P00747 2/20 0.42
PLAU P00749 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7209799 1.00 L3MBTL1 (0.52) L3MBTL1TACR2KMT2ACAPN1MEN1
Hydrochloric Acid SCHEMBL8205863 0.91 L3MBTL1 (0.49) L3MBTL1KMT2ACAPN1MEN1POLB
SCHEMBL7204793 0.86 KDM4E (0.49) L3MBTL1KMT2AMEN1
SCHEMBL7206727 0.86 L3MBTL1 (0.59) L3MBTL1CAPN1POLBCHRNB2CHRNB4
SCHEMBL8349149 0.86 L3MBTL1 (0.59) L3MBTL1CAPN1POLBCHRNB2CHRNB4
SCHEMBL7206720 0.86 L3MBTL1 (0.59) L3MBTL1CAPN1POLBCHRNB2CHRNB4
SCHEMBL7205257 0.83 MMP9 (0.50) KMT2ACAPN1MEN1F13A1TGM2
SCHEMBL7205260 0.83 MMP9 (0.50) KMT2ACAPN1MEN1F13A1TGM2
SCHEMBL7204787 0.82 L3MBTL1 (0.43) L3MBTL1TACR2CAPN1POLB
Hydrochloric Acid SCHEMBL7205771 0.82 KMT2A (0.47) KMT2ACAPN1MEN1F13A1TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921122-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2003-05-21 EP disclosed
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
EP-0921122-A1 NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-06-09 EP disclosed